BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan S, Mahalingam R, Sen S, Martinez-Ledesma E, Khan A, Gandy K, Lang FF, Sulman EP, Alfaro-Munoz KD, Majd NK, Balasubramaniyan V, de Groot JF. Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells. Cancers (Basel) 2021;13:5284. [PMID: 34771447 DOI: 10.3390/cancers13215284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Blomberg E, Silginer M, Roth P, Weller M. Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models. Transl Oncol 2023;28:101607. [PMID: 36571986 DOI: 10.1016/j.tranon.2022.101607] [Reference Citation Analysis]
2 Shi M, Ge Q, Wang X, Diao W, Yang B, Sun S, Wang G, Liu T, Chan AM, Gao Z, Wang Y, Wang Y. Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.910728] [Reference Citation Analysis]
3 Vella V, De Francesco EM, Bonavita E, Lappano R, Belfiore A. IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis. Trends Endocrinol Metab 2022;33:569-86. [PMID: 35691786 DOI: 10.1016/j.tem.2022.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Finocchiaro G, Berzero G. Glioblastomas. Cancers 2021;14:104. [DOI: 10.3390/cancers14010104] [Reference Citation Analysis]